Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 97, 115-119
Abstract
No abstract availableKeywords
Funding Information
- Chinese National Scientific Foundation to Weifeng Mao (81201563)
- Chinese National Scientific Foundation to Weifeng Mao (31371254)
This publication has 26 references indexed in Scilit:
- Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic StressScience, 2013
- Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast CancerCancer Discovery, 2012
- Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesisNucleic Acids Research, 2012
- The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaksNature Structural & Molecular Biology, 2012
- X-ray repair cross-complementing protein 1 (XRCC1) deficiency enhances class switch recombination and is permissive for alternative end joiningProceedings of the National Academy of Sciences, 2012
- Stumbling Blocks on the Path to Personalized Medicine in Breast Cancer: The Case of PARP Inhibitors for BRCA1/2-Associated CancersCancer Discovery, 2011
- PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutationsNature Reviews Clinical Oncology, 2010
- Purified human BRCA2 stimulates RAD51-mediated recombinationNature, 2010
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining PathwayAnnual Review of Biochemistry, 2010
- Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1Oncogene, 2005